Search: Lamivudine   Books Alphabetical: A to ZAlphabetical: Z to AAvg. Customer ReviewBestsellingFeatured ItemsPrice: High to LowPrice: Low to HighPub Date: New to Old Telbivudine tops lamivudine for HBV at 2 years.(Gastroenterology)(hepatitis B virus): An article from: Internal Medicine News by: Diana Mahoney Bioportfolio's Price: $9.95 Prices subject to change. This product in another region: UK | USA Lamivudine is still useful against some hepatitis B.(Gastroenterology)(Clinical report): An article from: Internal Medicine News by: Sherry Boschert Bioportfolio's Price: $9.95 Prices subject to change. This product in another region: UK | USA Simultaneous determination of lamivudine, stavudine and nevirapine in antiretroviral fixed dose combinations by high performance liquid chromatography [An article from: Analytica Chimica Acta] by: N. Kapoor, S. Khandavilli, R. Panchagnula Bioportfolio's Price: $10.95 Prices subject to change. This product in another region: UK | USA Late failure of combined recombinant hepatitis B vaccine and lamivudine in treatment of a patient with chronic hepatitis B.(Case Report): An article from: Southern Medical Journal by: Kendal Yalcin, Halil Degertekin, Mithat Bozdayi Bioportfolio's Price: $5.95 Prices subject to change. This product in another region: UK | USA Hepsera reduces lamivudine-resistant HBV levels in liver transplant patients.(hepatitis B): An article from: Transplant News from: Transplant Communications, Inc. Bioportfolio's Price: $5.95 Prices subject to change. This product in another region: UK | USA Lamivudine delays progress of chronic hepatitis B: long-term treatment.(Clinical Rounds): An article from: Family Practice News by: Sharon Worcester Bioportfolio's Price: $5.95 Prices subject to change. This product in another region: UK | USA Lamivudine puts brakes on advanced HBV infection: vaccine therapy may be useful adjunct: disease progression cut by two-thirds.(News): An article from: Internal Medicine News by: Sharon Worcester Bioportfolio's Price: $5.95 Prices subject to change. This product in another region: UK | USA Treatment of HBV may be warranted in some; consider Tx if risk of cirrhosis, hepatitis.(Infectious Diseases)(hepatitis B infection): An article from: Pediatric News by: Sharon Worcester Bioportfolio's Price: $5.95 Prices subject to change. This product in another region: UK | USA Panel backs adefovir for chronic hepatitis B. (Benefit Seen in Lamivudine Resistance).: An article from: Internal Medicine News by: Elizabeth Mechcatie Bioportfolio's Price: $5.95 Prices subject to change. This product in another region: UK | USA Emergency prophylaxis may cut HIV seroconversion rate. (Study of 202 High-Risk Men).(Brief Article): An article from: Internal Medicine News from: International Medical News Group Bioportfolio's Price: $5.95 Prices subject to change. This product in another region: UK | USA page 1 of  2  1  2

Recent Searches for Books on Bioportfolio:

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.